Effects of specialised and centralised versus generalised and decentralised outpatient treatment for progressed bipolar disorder: Results from the CAG Bipolar randomised controlled trial

BACKGROUND: Clinical Academic Group (CAG) is a new organization of treatment bringing together clinical services, research, education, and training to provide evidence-based care. We aimed, for the first time, to investigate whether specialized and centralized outpatient treatment (CAG Bipolar) versus decentralized community-based treatment improves patient outcomes and satisfaction with care in patients with progressed bipolar disorder. METHODS: A pragmatic randomized controlled trial was undertaken with individual randomization to 1) specialized and centralized outpatient treatment in CAG Bipolar or 2) generalized and decentralized community-based outpatient treatment. The 12-month outcomes were 1) cumulated number and duration of psychiatric hospitalizations, and 2) psychotropic medication, coercion, self-rated depressive and manic symptoms, quality of life, perceived stress, and satisfaction with care. RESULTS: = 0.9) of psychiatric hospitalizations. Lithium (RR: 1.19 (95% CI: 1.05-1.33) and antipsychotics (RR: 1.09 (95% CI: 1.01-1.17), specifically quetiapine (RR: 1.17 (95% CI: 1.03-1.30), were prescribed more in the CAG Bipolar group, and CAG Bipolar patients were overall more satisfied with care including the skills of the professionals, information and the efficacy of the service. There was no difference in coercion, self-rated depressive or manic symptoms, quality of life or perceived stress. CONCLUSIONS: Specialized and centralized outpatient treatment for progressed bipolar disorder does not result in improvement in robust outcome measures such as hospitalization and coercion, but in the use of psychotropic medication concordant with international guidelines, and increased satisfaction with care.

Authors

Institutions

Publication Details

Journal
Psychological Medicine
Published
2026-11-20
DOI
https://doi.org/10.1017/s0033291726106606
Primary Topic
Bipolar Disorder and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Effects of specialised and centralised versus generalised and decentralised outpatient treatment for progressed bipolar disorder: Results from the CAG Bipolar randomised controlled trial

Maria Faurholt‐Jepsen, Jens Drachmann Bukh, Henrik Nørbak-Emig, Darius Mardosas et al.
Psychological Medicine
Bipolar Disorder and Treatment
article

Effects of specialised and centralised versus generalised and decentralised outpatient treatment for progressed bipolar disorder: Results from the CAG Bipolar randomised controlled trial

Maria Faurholt‐Jepsen, Jens Drachmann Bukh, Henrik Nørbak-Emig, Darius Mardosas, Natacha Blauenfeldt Kyster, Esben Budtz–Jørgensen, Birte Smidt, Lars Vedel Kessing, Maj Vinberg, Louise Behrend Rasmussen, Sarah Krarup Larsen, Asbjørn Risom, in cooperation with the CAG Bipolar Study Group, Ulla Knorr, Ida Hageman, Gudmunda Sirry Arnardottir, Ellen Margrethe Christensen
article en

Abstract

BACKGROUND: Clinical Academic Group (CAG) is a new organization of treatment bringing together clinical services, research, education, and training to provide evidence-based care. We aimed, for the first time, to investigate whether specialized and centralized outpatient treatment (CAG Bipolar) versus decentralized community-based treatment improves patient outcomes and satisfaction with care in patients with progressed bipolar disorder. METHODS: A pragmatic randomized controlled trial was undertaken with individual randomization to 1) specialized and centralized outpatient treatment in CAG Bipolar or 2) generalized and decentralized community-based outpatient treatment. The 12-month outcomes were 1) cumulated number and duration of psychiatric hospitalizations, and 2) psychotropic medication, coercion, self-rated depressive and manic symptoms, quality of life, perceived stress, and satisfaction with care. RESULTS: = 0.9) of psychiatric hospitalizations. Lithium (RR: 1.19 (95% CI: 1.05-1.33) and antipsychotics (RR: 1.09 (95% CI: 1.01-1.17), specifically quetiapine (RR: 1.17 (95% CI: 1.03-1.30), were prescribed more in the CAG Bipolar group, and CAG Bipolar patients were overall more satisfied with care including the skills of the professionals, information and the efficacy of the service. There was no difference in coercion, self-rated depressive or manic symptoms, quality of life or perceived stress. CONCLUSIONS: Specialized and centralized outpatient treatment for progressed bipolar disorder does not result in improvement in robust outcome measures such as hospitalization and coercion, but in the use of psychotropic medication concordant with international guidelines, and increased satisfaction with care.

Psychological MedicineVol. 56
University of Copenhagen (DK), Mental Health Services (DK), Amager Hospital (DK), Glostrup Hospital (DK)
Good health and well-being
Bipolar Disorder and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon